Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03037632 · ClinicalTrials.gov registry record · NA

DCM Precision Medicine Study

A NA study of Idiopathic Dilated Cardiomyopathy, sponsored by Ray Hershberger.

Active
Registry status
NA
Development phase
6,500
Enrollment target
20
Study locations

NCT03037632 is a NA study of Idiopathic Dilated Cardiomyopathy that is active but no longer recruiting, run by Ray Hershberger. The registered enrollment target is 6,500 participants. The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03037632, a NA study of Idiopathic Dilated Cardiomyopathy, is active but no longer recruiting, sponsored by Ray Hershberger.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
6,500 participants
Enrollment target
20
Study locations

Study Summary

The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has substantial genetic basis and to evaluate the effectiveness of a family communication intervention in improving the uptake and impact of family member clinical screening.

Interventions

  • BEHAVIORAL Family Heart Talk Booklet

Study Locations (20)

California

  • Cedars-Sinai Medical Center - Beverly Hills
  • UCLA Medical Center - Los Angeles
  • Stanford University - Palo Alto

Ohio

  • Cleveland Clinic - Cleveland
  • Ohio State University - Columbus

Alabama

  • University of Alabama at Birmingham - Birmingham

Arizona

  • University of Arizona Sarver Heart Center - Tucson

District of Columbia

  • Medstar Washington Hospital Center (DC) - Washington D.C.

Florida

  • South Miami Heart Center - Miami

Georgia

  • Emory University - Atlanta

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 6,500 participants
Start Date 2016-06-07
Est. Completion 2026-06-30
Phase NA

Sponsor

Ray Hershberger

1 total trials

What the Registry Record Tells You About NCT03037632

The ClinicalTrials.gov registry entry for NCT03037632 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ray Hershberger, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Idiopathic Dilated Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Family Heart Talk Booklet is the first listed.

NCT03037632 reports 20 study locations spanning 17 distinct geographic areas - top geographies include California, Ohio, Alabama.

Frequently Asked Questions

What is clinical trial NCT03037632 about?

NCT03037632 is a clinical study titled "DCM Precision Medicine Study". The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has substantial genetic basis and to evaluate the effectiveness of a family communication intervention in improving the uptake and impact of family member clinical screening.

What is the current status of trial NCT03037632?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 6,500 participants. The study started on 2016-06-07. Estimated completion is 2026-06-30.

What conditions does trial NCT03037632 study?

This clinical trial studies the following conditions: Idiopathic Dilated Cardiomyopathy.

What interventions are being tested in trial NCT03037632?

The interventions under investigation include: Family Heart Talk Booklet (BEHAVIORAL).

Who is sponsoring clinical trial NCT03037632?

This trial is sponsored by Ray Hershberger, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03037632 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.